| Revenue | SEK 3M | +9% |
| EBITDA | SEK 786K | +23% |
| Net profit | SEK 222K | +305% |
| Total assets | SEK 7,5M | +7% |
| Equity | SEK 410K | +118% |
| Employees | 0 | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 954 | 1 785 | 1 818 | 2 712 | 2 962 |
| Staff expenses | — | — | — | −12 | −10 |
| EBITDA | −3 089 | −2 440 | −1 011 | 636 | 786 |
| Depreciation & amort. | −2 366 | −300 | −11 106 | −308 | −327 |
| EBIT | −5 455 | −2 740 | −12 117 | 328 | 459 |
| Net financials | −321 | −386 | −95 | −188 | −237 |
| Profit before tax | −2 041 | 135 | −12 212 | 140 | 222 |
| Tax | 288 | −15 | — | −85 | — |
| Net profit | −1 753 | 120 | −12 212 | 55 | 222 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 622 | 15 954 | 6 350 | 7 080 | 7 547 |
| Equity | 2 386 | 2 506 | 133 | 188 | 410 |
| Long-term debt | 12 265 | 12 839 | 5 663 | 6 370 | 6 627 |
| Short-term debt | 1 971 | 609 | 553 | 522 | 510 |
| Total debt | 14 236 | 13 448 | 6 216 | 6 892 | 7 137 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SJ Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2024 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
| Person | Role here | Other companies |
|---|---|---|
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Anders Michael Lidefelt | Chairman | 0 companies |
| Hugo Erik Källsäter | Deputy Board Member | 0 companies |
| Lars David Källsäter | Chairman | 0 companies |
| Anne Viktoria Källsäter | Board of Directors | 0 companies |
| Nils Jonatan Fornander | Deputy Board Member | 0 companies |
| Leo David Källsäter | Board of Directors | 0 companies |